Resources for pursuing endocrine-related research opportunities
Endocrine researchers are at the core of solving many of the most pressing health problems of our time, from diabetes and obesity to infertility, bone health, thyroid conditions, and hormone-related cancers. Your work has led to incredible accomplishments and remarkable progress in the biological and biomedical sciences that have benefited the lives of millions of Americans.
NIH Promotes Return to Research in Health-Related Careers: Administrative supplements will be available to provide full or part-time mentored research training experiences for individuals with high potential to re-enter, re-integrate into, or re-train in an active research career after an interruption for family responsibilities or other qualifying circumstances. The grants are intended to provide scientists with an opportunity to update or extend their research skills and prepare them to re-establish their careers in basic biomedical, behavioral, clinical, translational, or social science research. Applications open Monday, October 9.
Funding Opportunity: Improving Care and Outcomes for Cancer Survivors in SGM Populations: The NCI intends to support the assessment of barriers to quality cancer treatment and follow-up care for sexual and gender minority (SGM) cancer survivors. Funding is intended to address a critical need for improved care delivery and outcomes for SGM cancer survivors, an underserved and understudied population that is at higher risk of poorer health outcomes. Letters of intent are due 30 days prior to the application date, which opens on Friday, January 5.
Loan Repayment Program Cycle for FY 2024: Applications for Fiscal Year (FY) 2024 NIH Loan Repayment Program (LRP) awards are now open. LRPs can repay up to $100,000 of qualified educational debt for those who are eligible and agree to perform NIH mission-relevant research. The objective of the LRP-IDB is to recruit and retain highly qualified health professionals from disadvantaged backgrounds into clinical research careers. Submit your application by Thursday, November 16.
NIH Loan Repayment Program: The NIH announced its Loan Repayment Program for researchers with student debt. View the eligibility criteria and program categories for these programs. Next application cycle is September 1–November 16.
Preventing Chronic Disease: Call for Papers: The Division of Diabetes Translation is partnering with CDC’s Preventing Chronic Disease Journal to develop a special collection of diabetes-specific papers. We encourage you to submit articles that reflect and showcase findings based on surveillance, epidemiological studies, implemented public health interventions, health services-related research, geographic information and spatial analyses, policy interventions, and program evaluation.
Integrity and Bias Awareness Training will be Required for NIH Reviewers: The NIH Center for Scientific Review (CSR) has developed two reviewer training modules (already successfully implemented by CSR for several review cycles) that will now be required by all reviewers prior to participating in NIH review meetings, effective for the May 2024 Council round. The first is on “bias awareness and mitigation”, and the second is on “review integrity”. Each training takes approximately 30 minutes and must be completed every three years.
The Role of Sleep Deficiency in Persons with Type 1 Diabetes: Funding will be available to support clinically relevant, mechanism focused research at the interface between sleep, circadian rhythms biology, T1D and cardiovascular disease. Multi-disciplinary teams bridging sleep/circadian, diabetes, and cardiovascular research are encouraged to apply by Wednesday, October 11.
Extramural Loan Repayment Program for Researchers: The Extramural Loan Repayment Program (LRP) repays up to $50,000 annually of a researcher's qualified educational debt in return for a commitment to engage in NIH mission-relevant research at a domestic, nonprofit, or government entity. External LRPs exist for clinical researchers, pediatric researchers, health disparities researchers, researchers in emerging areas critical to human health, individuals from disadvantaged backgrounds, contraception and infertility researchers, and researchers addressing the heterogeneity of obesity risk, related health outcomes, and response to treatment. Application due dates vary by topic.
Time-Sensitive Research Opportunities in Environmental Health Sciences: The NIH is funding novel environmental health research in which an unpredictable event or policy change provides a limited window of opportunity to collect human biological samples or environmental exposure data. The review and funding of these proposals are substantially quicker than typical grant cycles; this is accomplished with more frequent application due dates and expediting peer review, council concurrence and award issuance. The entire cycle, from submission to award, is expected to be within 4-6 months. Submit your application.
Research Supplements to Promote Diversity in Health-Related Research: The NIH and CDC are funding administrative supplements for projects that enhance the diversity of the research workforce by recruiting, mentoring, and supporting high school, undergraduate and graduate/clinical students, postbaccalaureate and post Masters individuals, postdoctoral researchers (including health professionals), and eligible investigators from diverse backgrounds. Submission dates vary by the awarding Institute/Center.
NIH Prohibits the Use of AI in Peer Review: The NIH issued a notice informing the extramural research community that the use of natural language processors, large language models, or other generative Artificial Intelligence (AI) technologies for analyzing and formulating peer review critiques for grant applications is prohibited. Uploading or sharing content or original concepts from an NIH grant application, contract proposal, or critique to AI tools violates the NIH peer review confidentiality and integrity requirements.
NIDDK Catalyst Award: The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Catalyst Award supports individual scientists who propose pioneering and transformational studies in topic areas of interest to NIDDK. Applications should be focused on major scientific challenges and have the potential to produce an unusually high impact. Submit your application by Thursday, September 28.
Medical Specialists’ Transition to Aging Research: Funding Opportunity: The goal of the Grants for Early Medical/Surgical Specialists' Transition to Aging Research (GEMSSTAR) program is to provide support for early career physician-scientists trained in medical specialties to launch careers as future leaders in aging-focused research. This funding opportunity invites applications to propose transdisciplinary aging research that will yield pilot data and experience for subsequent aging research projects. Apply by Monday, October 30.
COVID-19 Impacted NIMH Research Supplements: The purpose of this Notice of Special Interest (NOSI) is to outline priorities for providing supplemental funding to investigators and institutions with active National Institute of Mental Health (NIMH) awards that experienced significant setbacks as result of the COVID-19 pandemic, which were unable to be resolved with non-monetary options (e.g., modification to the project or re-budgeting to accomplish aims). Applications will be accepted on a rolling basis through Wednesday, April 1, 2026. Submit your application.
Small Research Grants for Innovations in Healthy Longevity Research: The National Institute on Aging (NIA) released a Notice of Special Interest (NOSI) to support research on aging, the aging process, and diseases and conditions associated with growing older. Submit your application by Wednesday, May 8
NIDDK Releases Report: Health Disparities and Equities: NIDDK announced the release of “Pathways to Health for All,” a new report from its Health Disparities and Health Equity Research Working Group of Council, which makes innovative recommendations to advance research in health equity and health disparities. It also includes guiding principles for embedding equity into research activities and tips for researchers who plan to engage in robust health equity research.
Tissue Regeneration in Osteoarthritis: The Advanced Research Projects Agency for Health agency launched their first program announcement: the Novel Innovations for Tissue Regeneration in Osteoarthritis (NITRO). NITRO seeks to develop new ways of helping the human body repair its own joints, with the goal of revolutionizing treatment for osteoarthritis. Submissions are closed but registration is still available for the September symposium. Join the program.
Drug and Vaccine Research Needs for During and Post Pregnancy: The Eunice Kennedy Shriver National Institute on Child Health and Human Development (NICHD) released drug, vaccine, and dietary supplement research needs for pregnant, postpartum, and lactating persons. Submit your responses by Monday, September 29
Secondary Analyses of Existing Datasets in Aging Research: The National Institute on Aging encourages the use of existing cohorts and datasets for secondary analyses to investigate novel scientific ideas and/or address clinically related issues on: (1) aging changes influencing health across the lifespan (2) diseases and disabilities in older persons, and/or (3) the changes in basic biology of aging that underlie these impacts on health. First application has passed but receipt dates are still open through Wednesday, May 8, 2024.
Aging Research Dissertation Awards to Promote Diversity: The National Institute on Aging invites R36 applications to support senior graduate students with Aging Research Dissertation Awards to Promote Diversity. These awards provide funding to support graduate students from diverse backgrounds, including those from groups underrepresented in the biomedical and behavioral sciences, in finishing their dissertations on aging and aging-related health conditions. Submit your application for receipt dates through October 16, 2024.
Virtual EDC and Women’s Health Symposium: The Health and Human Services Office on Women’s Health hosted a symposium on endocrine disrupting chemicals (EDCs) and women’s health on July 18-19, 2023. This virtual symposium featured federal and non-federal stakeholders in the fields of research, prevention, and treatment, focusing on the impact of EDCs on women’s health, and explored actionable solutions addressing evidence to policy and practice gaps. Watch the session recordings.
Funding Opportunity on Clinical Trial Readiness for Rare Diseases: This funding opportunity invites researchers to submit applications for support of projects that address critical needs for clinical trial readiness in rare diseases. The initiative seeks applications that facilitate rare diseases research by enabling efficient and effective movement of candidate therapeutics or diagnostics toward clinical trials, and to increase their likelihood of success through development and testing of rigorous biomarkers and clinical outcome assessment measures, or by defining the presentation and course of a rare disease to enable the design of upcoming clinical trials. View the awards cycles and applicate due dates that extend through Thursday, October 17, 2024.
Interventions to Expand Cancer Screening and Prevention in Populations that Experience Health Disparities: The Office of Disease Prevention (ODP) and participating National Institutes of Health (NIH) Institutes, Centers, and Offices (ICs) are soliciting applications to address barriers and facilitators that impede use or uptake of cancer screening and preventive services in populations that experience health disparities. Interventions should include screening, preventive services, or other healthcare processes, including timely follow-up of abnormal findings, and referral to accessible care. Projects are encouraged to leverage collaborations with community partners and service providers. Apply by Thursday, October 5.
Urge Congress to Increase Funding for the NIH in FY2024: Congress is beginning the process of determining funding for the National Institutes of Health in fiscal year (FY) 2024. This will affect all researchers who receive grant funding from NIH. There is a lot of pressure coming from certain groups within Congress to cut funding significantly for all programs, including NIH. This is why the Endocrine Society needs all NIH-funded endocrine researchers to help us prevent funding cuts and advocate for increased funding. The Endocrine Society is urging Congress to provide $51 billion for the NIH base budget, which is a 7.3% increase over FY 2023. Our number reflects a 2.3% increase to account for biomedical inflation plus a 5% increase in real growth. To ensure increased funding for the NIH, it is critical that your Representative and Senators hear from you about this issue.
Transformative Research Awards: The NIH Director’s Transformative Research Award Program supports individual scientists or groups of scientists proposing groundbreaking, exceptionally innovative, original, and/or unconventional research with the potential to create new scientific paradigms, establish entirely new and improved clinical approaches, or develop transformative technologies. Individuals from diverse backgrounds, including those from underrepresented groups, are strongly encouraged to apply. Submit your application by Friday, September 1
Funding Research with Activities Related to Diversity (ReWARD): The NIH’s ReWARD Program provides support for the health-related research of scientists who are making a significant contribution to Diversity, Equity, Inclusion, and Accessibility (DEIA) and who have no current NIH research project grant funding. Review the awards cycle for this program that provides funding for both the scientific research and the DEIA activities of investigators.
Pioneer Award Program: Applications Now Open for Innovative Research Projects: The NIH Director’s Pioneer Award Program supports individual scientists of exceptional creativity who propose highly innovative research projects with the potential to produce a major impact on broad, important areas relevant to the mission of NIH. Individuals from all backgrounds and from the full spectrum of eligible institutions in all geographic locations are strongly encouraged to apply to this award. Applications in all topics relevant to the broad mission of NIH are welcome, including basic, translational, or clinical research. To be considered pioneering, the proposed research must reflect substantially different scientific directions from those already being pursued in the investigator’s research program or elsewhere. Apply by Friday, September 8.
Pilot Interventions to Improve Health Equity Pre-Application Webinar: The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) will host a pre-application webinar on Monday, May 15 about Pilot Interventions to Integrate Social Care and Medical Care to Improve Health Equity. This funding will support pilot and feasibility trials to test interventions that involve screening for and addressing adverse social determinants of health during a health care visit. The webinar will cover the application review process, and answer questions from prospective applicants. View webinar slides and FAQs.
NIDDK Issuing Small R01s for Clinical Trials: There is a funding opportunity for the submission of pilot and feasibility clinical trials in humans that will lay the foundation for larger clinical trials related to the prevention and/or treatment of diseases and conditions within the mission of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). For more information, please review the full notice.
Chronic Conditions Understudied Among Women: The purpose of this funding opportunity is to invite R01 applications on chronic conditions understudied among women and/or that disproportionately affect populations of women who are understudied, underrepresented, and/or underreported in biomedical research. View the application deadlines and the award cycles.
Postbac Research Education Programs in Diabetes, Endocrinology, and Metabolic Diseases: This R25 program provides funding support to eligible domestic institutions to develop and implement Postbaccalaureate (postbac) Research Education Programs in Diabetes, Endocrinology and Metabolic Diseases. These post-baccalaureate research programs will incorporate extensive research experiences and courses for skills development to prepare recent college graduates from diverse backgrounds to transition into and complete rigorous, research-focused biomedical doctoral degree programs. Apply by Thursday, October 26.
Exploratory Health Disparities Research Grant: The National Institute on Minority Health and Health Disparities (NIMHD) announced a grant to fund new exploratory or developmental research projects that have the potential to break new ground in the fields of minority health and health disparities. View the deadlines and awards cycle.
Addressing the Impact of Structural Racism and Discrimination in Minority Health and Health Disparities: The NIH announced a new R01 that will support intervention research to address the impact of structural racism and discrimination (SRD) on minority health and health disparities. Research designs should allow for the assessment of mechanisms through which the intervention modifies SRD and how these changes result in improvement in the targeted health outcomes. Application deadlines and the award cycles are now available.
Reminder: Updated NIH Policy for Data Management and Sharing Took Effect: The updated NIH Data Management and Sharing (DMS) Plan took effect on Wednesday, January 25. The DMS Policy applies to all NIH research, and DMS Plans should describe how data will be managed and appropriately shared. Learn more about the policy and its requirements. The Federation of American Societies for Experimental Biology (FASEB) has also put together excellent resources to help with the transition to this new policy.
Time-Sensitive Research Opportunities in Environmental Health Sciences: The NIH released a funding opportunity announcement (FOA) that is intended to support novel environmental health research in which an unpredictable event or policy change provides a limited window of opportunity to collect human biological samples or environmental exposure data. A feature of an appropriate study is the need for rapid review and funding; the entire cycle, from submission to award, is expected to be within 4-6 months. Review the deadlines and award cycles.
Climate Change and Healthcare Research: The Agency for Healthcare Research and Quality (AHRQ) are interested in receiving health services research grant applications that address the intersection of climate change and healthcare. Specifically, applications that address three primary areas: 1) Reducing the healthcare sector’s greenhouse gas emissions and carbon footprint, 2) Creating resilient healthcare systems and communities that can plan, prepare, respond, and adapt to climate-related threats, and 3) Addressing the inequitable impacts of climate change. Learn more.
Validation of Biomarker Assays Revision Applications: The National Cancer Institute (NCI) is encouraging revision applications from currently funded NCI R01 research projects. The focus of applications submitted should be on the adaption and clinical validation of molecular/cellular/imaging biomarkers for cancer detection, diagnosis, prognosis, monitoring, and prediction of response in treatment, as well as markers for cancer prevention and control.
Mood and Psychosis Research During the Menopause Transition: The NIH issued a funding opportunity announcement (FOA) to encourage applications that will advance mechanistic and translational research on the onset and worsening of mood and psychotic disorders during the menopausal transition. In particular, they are seeking proposals that will advance the understanding of the underlying neurobiological and behavioral mechanisms during the menopause transition that will identify novel targets for future mental health interventions. Learn more.
NIH Grants Policy Changes: The NIH announced that they have published updated “Significant Changes” made to the NIH Grants Policy Statement (GPS) in fiscal year 2022 that will be reflected in the GPS for 2023. Highlights include an updated definition of terms (added the data management and sharing plan, unique entity identifier, etc.), a new section titled “NIH Disclosure Requirements,” and a new section titled “Plans to Promote Safe Environments at Conferences”, among others. about the changes.
Continuity of Research Among First-Time NIH Grant Recipients Administrative Supplement: This retention program seeks to maintain the productivity of current first-time recipients of eligible independent NIH research project grant awards who are dealing with a critical life event(s), such that they can remain competitive for the first renewal of their award or for a second research project grant award. The overarching goal of this program is to enhance the retention of investigators facing critical life events who are transitioning to the first renewal of their first independent research project grant award or to a second new NIH research project grant award. Learn more.
Administrative Supplements to Recognize Excellence in DEIA Mentorship: The NIH announced a notice of special interest (NOSI) wherein participating Institutes and Centers (ICs) invite applications to support administrative supplements to existing NIH awards and ongoing future efforts. These supplements will support scientists who have demonstrated compelling commitments and contributions to mentorship and enhancing diversity, equity, inclusion, and accessibility (DEIA) in the biomedical sciences. The webinar recording is now available.
Trailblazer Award Opportunity for New and Early Stage Investigators: The Trailblazer Award is an opportunity for new and early stage investigators to pursue research programs that integrate engineering and the physical sciences with the life and/or biomedical sciences. A Trailblazer project may be exploratory, developmental, proof of concept, or high risk-high impact, and may be technology design-directed, discovery-driven, or hypothesis-driven. Applicants must propose research approaches for which there are minimal or no preliminary data. View the application due dates and award cycles.
Maximizing Investigators’ Research Award for Early Stage Investigators: The National Institute of General Medical Sciences (NIGMS) announced they are planning to issue a funding opportunity announcement (FOA) to continue the Maximizing Investigators’ Research Award for Early Stage Investigators (MIRA-ESI) R35 program. ESIs are encouraged to submit an application that falls within the mission of NIGMS.
Urgent Competitive Revisions to Existing NIH Grants: The NIH announced that Principal Investigators on specific types of NIH research grants may apply to funds for competitive revisions to meet immediate needs to help address a specific public health crisis which were unforeseen when the application was submitted. Applications for Urgent Competitive Revisions will be routed directly to the NIH awarding component listed on the Notice of Award of the most recent parent award. Review the full notice.
Improving Management of Exercise for People with T1D: The Leona M. and Harry B. Helmsley Charitable Trust’s (Helmsley) Type 1 Diabetes (T1D) Program is launching a Request for Proposals (RFP) to support the development of novel, real-world solutions to help people with T1D exercise safely and to improve their quality of life. Researchers and clinicians are expected to partner with statistical teams to analyze the real-world data that was collected under Helmsley’s T1D Exercise Initiative (T1-DEXI), build collaborations with other necessary third parties, and to test their novel solutions in studies with people with T1D. The overarching purpose of this initiative is to move real-world data towards real-world solutions. View RFP for details and deadlines
Women’s Health Research in Institutional Development Award (IDeA)-eligible States: The NIH announced a Notice of Special Interest (NOSI) to support women’s health research in Institutional Development Award (IDeA)-eligible states. The proposed research must address at least one of the strategic goals of the Trans-NIH Strategic Plan for Women's Health Research “Advancing Science for the Health of Women” to enable innovative research relevant to the health of women and to address emerging women’s health issues of public importance. The first available due date is Monday, January 30. View all the deadlines.
Resources and Technologies for Enhancing Rigor and Reproducibility: The Office of Research Infrastructure Programs (ORIP) encourages research project grant applications aimed at developing and implementing broadly applicable technologies, tools, and resources for validating animal models and enhancing rigor, reproducibility, and translatability of animal research. The earliest submission date is February 5. Review the award cycles.
Intersection of Sex and Gender Influences on Health and Disease: The NIH issued a funding opportunity announcement (FOA) to invite R01 applications on the influence and intersection of sex and gender in health and disease. This FOA supports basic, preclinical, translational, and clinical research investigations. Review the application deadlines and award cycles.
NCI Pathway to Independence Award Pre-Application Webinar: The National Cancer Institute (NCI) held a pre-application webinar for the funding opportunity announcement (FOA), NCI Pathway to Independence Award for Outstanding Early-Stage Postdoctoral Researchers. NCI staff members will provide orientation to potential applicants by explaining the goals and objectives for the FOAs and answer questions from webinar attendees. View recording.
Increase to K99 Support Levels: The National Institute of General Medical Sciences (NIGMS) announced it will raise the maximum salary, research, and total support levels provided on NIGMS K99 awards issued in Fiscal Year 2023. Learn more.
Development of Animal Models and Related Materials Funding: The Office of Research Infrastructure Programs (ORIP) issued a Funding Opportunity Announcement (FOA) encouraging grant applications aimed at developing, characterizing or improving animal models of human diseases. The animal models, related materials, or technological tools developed must be broadly applicable to the scientific interests of two or more NIH Institutes or Centers and must evaluate diseases and processes that impact multiple organ systems. Applications will be accepted on a rolling basis through May 26, 2025. For more information, please review the application due dates and award cycles.
Time-Sensitive Opportunities for Health Research: The NIH issued a funding opportunity announcement (FOA) that establishes an accelerated review process to support research to understand health outcomes related to an unexpected and/or time-sensitive event (e.g., emergent environmental threat; pandemic; change in local, state, or national policy; natural disaster). The time from submission to award is expected to occur within 4-5 months. Applications will be accepted on a rolling basis through November 2, 2023.
Cancer Moonshot Scholars Diversity Program: The National Cancer Institute (NCI) issued a funding opportunity announcement (FOA) that supports the Cancer Moonshot Scholars Diversity Program. This FOA solicits R01 grant applications that propose independent research projects within the scientific mission of the NCI. The overarching goal of this program is to increase the number of R01 Early Stage Investigators and enhance the diversity of the cancer research workforce. Review the table for grant deadlines.
Data Management and Sharing Policy Implementation Details: The NIH released a notice to inform the extramural research community of implementation details for the new Policy for Data Management and Sharing (DMS) Policy. Applications submitted after Wednesday, January 25, 2023 will be required to submit a DMS Plan.
Type I Diabetes Clinical Studies Funding for Collaborative Research Using Biosamples: The National Institute of Diabetes and Digestive Kidney Diseases (NIDDK) issued a funding opportunity announcement (FOA) soliciting applications for studies of type I diabetes etiology and pathogenesis using data and samples from clinical trials and studies. Letter of Intent Due Date: January 28, 2023 and September 26, 2023. Access the grant deadlines.
Notice of Information on Sex and Gender Influences on the Adolescent Brain and Mental Health of Girls: The National Institute of Mental Health (NIMH) issued a Notice of Information outlining priorities for potential applications in the field of women’s mental health research. Both basic and translational research projects are encouraged that examine biological, social, cultural, and behavioral contributions of sex and gender influences on mental illnesses (e.g., anxiety, depression, psychosis, schizophrenia, bipolar disorder, trauma-related disorders, eating disorders, etc.) autism spectrum disorder and suicide in adolescent girls and young women (Ages 12-24).Learn more.
The National Cancer Institute (NCI)issued a notice of intent to publish a funding opportunity announcement inviting R01 and R21 applications for research projects that identify and define the mechanisms that link diet with lipid metabolism-mediated tumor growth and progression. For more information, please see the full notice for the R01 and R21.
The National Cancer Institute (NCI) Funding Opportunity for Cancer Research: NCI issued a funding opportunity announcement (FOA) to support studies for a Phase II or later phase trial. The NCI intends to support clinical trials aimed at improving cancer prevention/interception, cancer-related health behaviors, screening, early detection, healthcare delivery, management of treatment-related symptoms, supportive care, and the long-term outcomes of cancer survivors. View the awards cycles and applicate due dates that extend through Wednesday, June 25, 2025. Learn more.
NIH Extends Some COVID-19 Flexibilities: The National Institutes of Health issued a notice extending the special exception for post-submission material to applications submitted for the January 2023 Council rounds. NIH, AHRQ, and NIOSH will accept a one-page update with preliminary data as post-submission materials for applications submitted under all activity codes, only if the Funding Opportunity Announcement (FOA) used for submission allowed preliminary data in the application. One page of preliminary data will be accepted for single component applications or for each component of a multi-component application. The deadline for submitting all post-submission materials, including preliminary data, will be 30 days before the study section meeting, unless specified otherwise in the FOA.
NIA Announces K22 Awards: The National Institute of Aging (NIA) announced the NIA Career Transition Award (CTA) to facilitate the transition of mentored researchers to tenure-track faculty positions conducting research that advances the mission of NIA. This award will provide three years of protected time through salary and research support to conduct biomedical research at an extramural sponsoring institution/organization to which the individual has been recruited, been offered, and has accepted a tenure-track full-time assistant professor position (or equivalent). Expiration date is October 13, 2024. Learn more.
NIH Issues MOSAIC FOAs: The Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) program is part of NIH’s efforts to enhance diversity within the academic biomedical research workforce, and is designed to facilitate the transition of promising postdoctoral researchers from diverse backgrounds, for example individuals from groups underrepresented in the biomedical research workforce at the faculty level, into independent, tenure-track or equivalent research-intensive faculty positions. Expiration date is September 8, 2024. Please see the relevant guide notices (clinical trial not allowed, independent clinical trial required, and independent basic experimental studies with humans required) for more information.
NIH NOSI Supports Returning Biomedical Researchers: NIH has announced a new supplements program for researchers returning to biomedical careers after a qualifying absence. Under this Notice of Special Interest, applicants can apply to participate in full- or part-time mentored research experiences through existing NIH research grants. Eligible for these reentry supplements are individuals whose research careers have been interrupted for at least 6 months because of family responsibilities or other qualifying circumstances. Learn more, including detailed eligibility requirements. Apply through Saturday, October 7.
NOSI for Placental Research: The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) issued a Notice of Special Interest (NOSI) encouraging research on several “High Priority Areas in Placental Research for Healthy Pregnancies”. Topics of special emphasis in these areas include, but are not limited, to 1) Elucidating the gene-regulatory pathways and molecular mechanisms involved in trophoblast differentiation and function; 2) Understanding the role of the immune system in normal placentation and pregnancy rejection; and 3) Developing safe and effective therapeutics for the treatment of placental dysfunction/disorders. Research addressing themes of diversity and inclusion are also highly encouraged. The notice expires October 6, 2024.
NOSI on Physical Activity Interventions: The Office of Disease Prevention and participating NIH Institutes and Centers issued a Notice of Special Interest (NOSI) to highlight their interest in encouraging highly innovative and promising translational research to improve our understanding of how to increase and maintain health-enhancing physical activity using multi-level interventions in a wide range of population groups across the lifespan. The notice applies to a number of grant mechanisms, and expires on February 16, 2024. For more information, please see the full notice.
NOSI for Secondary Analysis of Human Connectome Data: Several NIH institutes issued a Notice of Special Interest (NOSI) to encourage secondary analyses of data from the Human Connectome Project (HCP) including the multiple datasets in the Lifespan Human Connectome projects and the Human Connectomes Related to Human Disease. Applicants beyond the groups that originally collected the data are encouraged to apply. For more information, see the announcement in the grants guide or the website for the Connectome Coordination Facility. The expiration date is May 8, 2024.
NIH Launches New Early Investigator Grant: National Institutes of Health recently announced the Stephen I. Katz Early Stage Investigator Research Project Grant award. This new award will support early stage investigators (ESIs) for innovative projects in an area of science that represents a change in research direction for the investigator. Importantly, applications will not be allowed to submit preliminary data. The final application due date for non-AID applications is September 26, 2023, and for AIDS and AIDS-related applications is December 28, 2023. For other information, see the NIH Notice.
The following resources may be useful for researchers seeking data repositories, databases, or other opportunities for data deposition and/or sharing.
Carol A. Lange, PhD, Editor-in-Chief of Endocrinology, and Stephen R. Hammes, MD, PhD, past Editor-in-Chief of Molecular Endocrinology share critical tips on how to get published.
Carol A. Lange, PhD, Editor-in-Chief of Endocrinology, shares why you should submit your research to our journal. The Society now waives page and color charges for Society members. The journal has also seen a surge of citations.
Congress is in the process of determining funding for the National Institutes of Health (NIH) in fiscal year (FY) 2024. This will affect all researchers who receive grant funding from NIH. To protect NIH from severe cuts, it is critical that your Representative and Senators hear from you about this issue.
